Overview
Sinead Loughran practices practicing medicine in Dundalk, Ireland.
Her clinical expertise encompasses Parainfluenza Virus Type 3, Flu, and Complex Regional Pain Syndrome.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sinead T. Loughran
Is Sinead T. Loughran a top-rated expert for Parainfluenza Virus Type 3?
MediFind is an objective health platform that identifies experts based on real-world data. Sinead T. Loughran is classified as an Experienced expert for Parainfluenza Virus Type 3, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sinead T. Loughran participate in research or clinical trials?
Yes. Sinead T. Loughran has published 21 articles and abstracts on conditions like Parainfluenza Virus Type 3. You can view a list of Sinead T. Loughran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Complex Regional Pain SyndromeMs. Loughran isExperienced. Learn about Complex Regional Pain Syndrome.
- FluMs. Loughran isExperienced. Learn about Flu.
- Parainfluenza Virus Type 3Ms. Loughran isExperienced. Learn about Parainfluenza Virus Type 3.